US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
SE9600072D0
(sv)
*
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients II
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
US6096340A
(en)
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
ES2362418T3
(es)
*
|
1997-12-08 |
2011-07-05 |
Nycomed Gmbh |
Nueva forma de supositorio que comprende un compuesto activo ácido-lábil.
|
DK173431B1
(da)
*
|
1998-03-20 |
2000-10-23 |
Gea Farmaceutisk Fabrik As |
Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
|
WO1999059544A2
(en)
|
1998-05-18 |
1999-11-25 |
Takeda Chemical Industries, Ltd. |
Orally disintegrable tablets
|
CA2525555A1
(en)
|
1998-07-28 |
2000-02-10 |
Takeda Pharmaceutical Company Limited |
Rapidly disintegrable solid preparation
|
SE9803772D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
CN1348333A
(zh)
*
|
1999-04-01 |
2002-05-08 |
Wm.雷格利Jr.公司 |
用于口香糖的风味剂长期持续释放结构
|
US6428809B1
(en)
*
|
1999-08-18 |
2002-08-06 |
Microdose Technologies, Inc. |
Metering and packaging of controlled release medication
|
US6521255B2
(en)
*
|
2000-01-13 |
2003-02-18 |
Osmotica Corp. |
Osmotic device containing ranitidine and a prokinetic agent
|
US6623758B2
(en)
|
2000-02-24 |
2003-09-23 |
Advancis Pharmaceutical Corp. |
Cephalosporin-metronidazole antibiotic composition
|
US6667042B2
(en)
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Fluroquinilone antibiotic product, use and formulation thereof
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US6632453B2
(en)
|
2000-02-24 |
2003-10-14 |
Advancis Pharmaceutical Corp. |
Ciprofoxacin-metronidazole antibiotic composition
|
US6730320B2
(en)
|
2000-02-24 |
2004-05-04 |
Advancis Pharmaceutical Corp. |
Tetracycline antibiotic product, use and formulation thereof
|
US6991807B2
(en)
*
|
2000-02-24 |
2006-01-31 |
Advancis Pharmaceutical, Corp. |
Antibiotic composition
|
AU2001239841B2
(en)
|
2000-02-24 |
2006-04-27 |
Shionogi, Inc. |
Antibiotic and antifungal compositions
|
US6669948B2
(en)
|
2000-02-24 |
2003-12-30 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6610328B2
(en)
|
2000-02-24 |
2003-08-26 |
Advancis Pharmaceutical Corp. |
Amoxicillin-clarithromycin antibiotic composition
|
US6663891B2
(en)
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Erythromyacin antibiotic product, use and formulation thereof
|
US6627222B2
(en)
|
2000-02-24 |
2003-09-30 |
Advancis Pharmaceutical Corp. |
Amoxicillin-dicloxacillin antibiotic composition
|
US6638532B2
(en)
|
2000-02-24 |
2003-10-28 |
Advancis Pharmaceutical Corp. |
Tetracycline—doxycycline antibiotic composition
|
US6663890B2
(en)
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Metronidazole antibiotic product, use and formulation thereof
|
US7025989B2
(en)
*
|
2000-02-24 |
2006-04-11 |
Advancis Pharmaceutical Corp. |
Multiple-delayed released antibiotic product, use and formulation thereof
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6667057B2
(en)
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Levofloxacin antibiotic product, use and formulation thereof
|
MXPA02009534A
(es)
|
2000-03-30 |
2003-05-14 |
Squibb Bristol Myers Co |
Granulos de liberacion sostenida que contienen estavudina.
|
US20040146554A1
(en)
*
|
2000-07-15 |
2004-07-29 |
Sharma Virender K. |
Method for the administration of acid-labile drugs
|
WO2002026210A2
(en)
*
|
2000-09-29 |
2002-04-04 |
Geneva Pharmaceuticals Inc. |
Proton pump inhibitor formulation
|
US7074417B2
(en)
*
|
2000-10-13 |
2006-07-11 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-viral product, use and formulation thereof
|
US7157095B2
(en)
*
|
2000-10-13 |
2007-01-02 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release antifungal product, use and formulation thereof
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
US7105174B2
(en)
*
|
2000-10-13 |
2006-09-12 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-neoplastic product, use and formulation thereof
|
US20020197314A1
(en)
|
2001-02-23 |
2002-12-26 |
Rudnic Edward M. |
Anti-fungal composition
|
SE0101379D0
(sv)
*
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
JP2006282677A
(ja)
*
|
2001-10-17 |
2006-10-19 |
Takeda Chem Ind Ltd |
酸に不安定な薬物の高含量顆粒
|
ES2426723T3
(es)
|
2001-10-17 |
2013-10-24 |
Takeda Pharmaceutical Company Limited |
Gránulos que contienen gran cantidad de compuesto químico inestable en medio ácido
|
JP4331930B2
(ja)
*
|
2001-10-17 |
2009-09-16 |
武田薬品工業株式会社 |
酸に不安定な薬物の高含量顆粒
|
MXPA04007169A
(es)
*
|
2002-01-25 |
2004-10-29 |
Santarus Inc |
Suministro transmucosal de inhibidores de bomba de protones.
|
US7125563B2
(en)
*
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
SE0203065D0
(sv)
*
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
US9107804B2
(en)
|
2002-12-10 |
2015-08-18 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
US20040114368A1
(en)
*
|
2002-12-13 |
2004-06-17 |
Shyu Shing Jy |
Light device having rotatable or movable view
|
EP1596838A2
(de)
*
|
2003-02-11 |
2005-11-23 |
Torrent Pharmaceuticals Ltd |
Orale zubereitungen zur anwendung einmal am tag mit einem protonenpumpenhemmer und einem prokinetischen wirkstoff
|
US20040185119A1
(en)
*
|
2003-02-26 |
2004-09-23 |
Theuer Richard C. |
Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
|
BR8300543U
(pt)
*
|
2003-04-09 |
2004-11-23 |
Medley S A Ind Farmaceutica |
Embalagem, ou kit de medicamentos, ou apresentação facilitadora da administração de medicamentos por parte dos pacientes
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
WO2005009364A2
(en)
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
CA2533178C
(en)
|
2003-07-21 |
2014-03-11 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
CA2533292C
(en)
|
2003-07-21 |
2013-12-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
US20060165793A1
(en)
*
|
2003-08-04 |
2006-07-27 |
Koji Ukai |
Pharmaceutical preparation to be dispersed before administration
|
WO2005016311A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
JP5686494B2
(ja)
*
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
AU2004268641A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Dynogen Pharmaceuticals, Inc. |
Compositions useful for treating gastrointestinal motility disorders
|
EP1663169A4
(de)
|
2003-09-15 |
2010-11-24 |
Middlebrook Pharmaceuticals In |
Antibiotisches produkt, seine verwendung und formulierung
|
TWI372066B
(en)
*
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US7767768B2
(en)
*
|
2003-11-03 |
2010-08-03 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7608674B2
(en)
*
|
2003-11-03 |
2009-10-27 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising cross-linked small molecule amine polymers
|
US7335795B2
(en)
*
|
2004-03-22 |
2008-02-26 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
JP4740740B2
(ja)
*
|
2003-12-09 |
2011-08-03 |
大日本住友製薬株式会社 |
薬物含有粒子および該粒子を含む固形製剤
|
EA012261B1
(ru)
*
|
2004-01-06 |
2009-08-28 |
Панацея Биотек Лтд. |
Лекарственные формы, содержащие ингибитор протонного насоса и прокинетический агент
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
WO2005123042A1
(en)
*
|
2004-06-10 |
2005-12-29 |
Glatt Air Techniques, Inc. |
Controlled release pharmaceutical formulation
|
JP2008505124A
(ja)
|
2004-07-02 |
2008-02-21 |
アドバンシス ファーマスーティカル コーポレイション |
パルス送達用錠剤
|
CN1993132B
(zh)
*
|
2004-07-28 |
2010-05-05 |
大日本住友制药株式会社 |
具有多包衣层的膜-包衣片剂
|
AR052225A1
(es)
*
|
2004-11-04 |
2007-03-07 |
Astrazeneca Ab |
Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
|
AR051654A1
(es)
*
|
2004-11-04 |
2007-01-31 |
Astrazeneca Ab |
Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
|
WO2006066932A1
(en)
*
|
2004-12-24 |
2006-06-29 |
Lek Pharmaceuticals D.D. |
Stable pharmaceutical composition comprising an active substance in the form of solid solution
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
JP4972563B2
(ja)
*
|
2006-01-20 |
2012-07-11 |
大日本住友製薬株式会社 |
新規なフィルムコーティング錠
|
US20090068263A1
(en)
*
|
2006-04-20 |
2009-03-12 |
Themis Laboratories Private Limited |
Multiple unit compositions
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US20100297226A1
(en)
*
|
2006-06-01 |
2010-11-25 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
US8439033B2
(en)
|
2007-10-09 |
2013-05-14 |
Microdose Therapeutx, Inc. |
Inhalation device
|
EP2344139A1
(de)
*
|
2008-09-09 |
2011-07-20 |
AstraZeneca AB |
Verfahren zur abgabe einer pharmazeutischen zusammensetzung an einen patienten, der diese benötigt
|
JP2012518655A
(ja)
*
|
2009-02-23 |
2012-08-16 |
アプタリス ファーマテック インコーポレイテッド |
プロトンポンプ阻害剤を含む制御放出組成物
|
US8758779B2
(en)
*
|
2009-06-25 |
2014-06-24 |
Wockhardt Ltd. |
Pharmaceutical composition of duloxetine
|
EP2445499A4
(de)
|
2009-06-25 |
2013-02-27 |
Astrazeneca Ab |
Verfahren zur behandlung eines patienten mit risiko der entwicklung eines nsaid-assoziierten geschwürs
|
EP2501383A4
(de)
*
|
2009-11-20 |
2013-06-26 |
Handa Pharmaceuticals Llc |
Orale formulierung für dexlansoprazol
|
WO2011085022A1
(en)
|
2010-01-05 |
2011-07-14 |
Microdose Therapeutx, Inc. |
Inhalation device and method
|
KR101143997B1
(ko)
*
|
2010-03-04 |
2012-05-09 |
한미사이언스 주식회사 |
유산균 제제 및 5-ht4 수용체 효능제를 함유하는 경구 투여용 복합 제제 및 이의 제조방법
|
WO2011126327A2
(en)
*
|
2010-04-09 |
2011-10-13 |
Hyundai Pharm Co., Ltd. |
Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof
|
EP2563341A1
(de)
*
|
2010-04-26 |
2013-03-06 |
Mahmut Bilgic |
Synergistische effekte auslösende pharmazeutische zusammensetzungen
|
BRPI1103093A2
(pt)
*
|
2011-06-03 |
2013-07-02 |
Eurofarma Laboratarios Ltda |
composiÇço farmacÊutica oral e uso da composiÇço farmacÊutica oral
|
BR112014016085A8
(pt)
|
2011-12-28 |
2017-07-04 |
Pozen Inc |
composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
|
JP6273302B2
(ja)
*
|
2013-03-15 |
2018-01-31 |
コリア ユナイテッド ファーマ. インコーポレーテッド |
1日1回の投与で薬理学的臨床効果を提供するモサプリド徐放性製剤
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
WO2016209061A1
(ko)
*
|
2015-06-26 |
2016-12-29 |
한국유나이티드제약 주식회사 |
모사프리드와 라베프라졸의 복합제제
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
KR102034694B1
(ko)
*
|
2017-12-14 |
2019-10-22 |
한국유나이티드제약 주식회사 |
모사프리드와 라베프라졸을 함유하는 유핵정 복합제제
|